Lymphoma Trial, Recruiting (NCT04904146)

Lymphoma Trial, Recruiting NCT04904146 Sponsor: Lund University Hospital Condition: Lymphoma

Printed from Voxsanity (voxsanity.com.au) — NCT04904146 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lymphoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 to 100 years old
People who have been diagnosed with Mycosis Fungoides (MF) or Sézary Syndrome (SS) at any stage (I through IV), confirmed through a tissue sample analysis using a recognised international classification system
People with a general health status ranging from fully active to limited self-care ability (as assessed by a standard medical scoring system called the WHO performance status scale, scores 0 to 3)
People who do not have a psychiatric illness or condition that could affect their ability to understand what taking part in the study involves
People who are able to provide written consent to participate, in line with international clinical trial standards
There are no specific blood test or laboratory result requirements for joining

Who may not be able to join:

No exclusion criteria have been specified for this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04904146

Sponsor: Lund University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Lymphoma

More information: https://clinicaltrials.gov/study/NCT04904146

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 to 100 years old
People who have been diagnosed with Mycosis Fungoides (MF) or Sézary Syndrome (SS) at any stage (I through IV), confirmed through a tissue sample analysis using a recognised international classification system
People with a general health status ranging from fully active to limited self-care ability (as assessed by a standard medical scoring system called the WHO performance status scale, scores 0 to 3)
People who do not have a psychiatric illness or condition that could affect their ability to understand what taking part in the study involves
People who are able to provide written consent to participate, in line with international clinical trial standards
There are no specific blood test or laboratory result requirements for joining

Who may not be able to join:

No exclusion criteria have been specified for this trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Lund University Hospital

Registry

ClinicalTrials.gov

Start date

2 April 2021

Est. completion

1 April 2027

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Identification of serum-protein markers.; Identification of serum-protein markers.; Identification of serum-protein markers.; Identification of serum-protein markers.; Identification of serum-protein markers.; Identification of serum-protein markers.; Identification of serum-protein markers.; Identification of immune cell profile-protein markers.; Identification of immune cell profile-protein markers.; Identification of immune cell profile-protein markers.; Identification of immune cell profile-protein markers.; Identification of immune cell profile-protein markers.; Identification of immune c...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov